Cemiplimab
Products in Health Canada’s databases that list Cemiplimab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 2
- 1 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 19
- Products in all
- 2
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| LIBTAYO (350 MG) | 02487144 | Marketed | Regeneron Canada Company | |
| LIBTAYO (250 MG) | 02487152 | Cancelled Post Market | Sanofi-Aventis Canada Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- LIBTAYOSeptember 24, 2026 · NOC 38343
- LIBTAYOJuly 13, 2026 · NOC 37888
- LIBTAYOJune 23, 2026 · NOC 37768
- LIBTAYOApril 30, 2026 · NOC 37475
- LIBTAYOMarch 23, 2026 · NOC 37159
- LIBTAYOSeptember 25, 2024 · NOC 34104
- LIBTAYOSeptember 13, 2024 · NOC 34012
- LIBTAYOJune 11, 2024 · NOC 33433
- LIBTAYOJanuary 19, 2024 · NOC 32573
- LIBTAYODecember 15, 2023 · NOC 32392
- LIBTAYOAugust 15, 2023 · NOC 31447
- LIBTAYOApril 27, 2023 · NOC 30578
- LIBTAYOMarch 23, 2022 · NOC 27799
- LIBTAYOOctober 26, 2021 · NOC 26919
- LIBTAYOAugust 13, 2021 · NOC 26447
- LIBTAYOJune 23, 2021 · NOC 26120
- LIBTAYOAugust 26, 2020 · NOC 24130
- LIBTAYOAugust 19, 2020 · NOC 24093
- LIBTAYOApril 10, 2019 · NOC 22053